Cargando…
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of...
Autores principales: | D’Erasmo, Laura, Minicocci, Ilenia, Di Costanzo, Alessia, Pigna, Giovanni, Commodari, Daniela, Ceci, Fabrizio, Montali, Anna, Brancato, Francesca, Stanca, Ilaria, Nicolucci, Antonio, Ascione, Andrea, Galea, Nicola, Carbone, Iacopo, Francone, Marco, Maranghi, Marianna, Arca, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200757/ https://www.ncbi.nlm.nih.gov/pubmed/33890476 http://dx.doi.org/10.1161/JAHA.120.018932 |
Ejemplares similares
-
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study
por: Catapano, Federica, et al.
Publicado: (2023) -
The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
por: Bini, Simone, et al.
Publicado: (2021) -
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019) -
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022) -
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)